A Biotech News Syndication

Moreover Biotech News

Lose 25 Pounds In 3 Weeks - Sponsored Link
Ad - Bride Loses 68 Pounds in 4 Months.As Seen on CNN and 60 Minutes.

German Merck Profit Soars on Serono Deal
FRANKFURT, Germany (AP) -- Merck KGaA, the German drug and chemical company whose products include the multiple sclerosis drug Rebif and cancer treatment Erbitux, said Monday that its fourth-quarter profit soared to nearly $5 billion as it reaped the

German Merck Profit Soars on Serono Deal
Article: :/n/a/2008/02/18/financial/f072442S24.DTL SFGate HomeNews Business Sports Entertainment Travel | Classifieds Jobs Real Estate Cars SFGate Web Search by YAHOO! German Merck Profit Soars on Serono Deal del.icio.us Digg Technorati Reddit

German Merck profit soars on Serono deal
FRANKFURT, Germany - Merck KGaA, the German drug and chemical company whose products include the multiple sclerosis drug Rebif and cancer treatment Erbitux, said Monday that its fourth-quarter profit soared to nearly $5 billion as it reaped the benefits

Eastern Biotech launches newborn screening test
Eastern Biotech launches newborn screening test Dubai-based biotechnology company Eastern Biotech & Life Sciences, announced it is now offering state-of-the-art, supplemental screening for more than 50 rare and treatable metabolic disorders (i.e.

ELN and LIMS Aid Biotechnology Growth
2008 Genetic Engineering & Biotechnology , All Rights Reserved -

Veritec to supply tribe with biometric IDs
Extract not available.

Germany's Merck 4Q profit soars near US$4.99B on Serono deal, generics sale
Matt Moore, The Associated Press FRANKFURT, Germany - Merck KGaA, the German drug and chemical company whose products include the multiple sclerosis drug Rebif and cancer treatment Erbitux, says its fourth-quarter profit soared to nearly 3.4 billion

German Merck Profit Soars on Serono Deal
Comments that include profanity or personal attacks or other inappropriate comments or material will be removed from the site. Additionally, entries that are unsigned or contain 'signatures' by someone other than the actual author will be removed.

German Merck Profit Soars on Serono Deal
FRANKFURT, Germany Merck KGaA, the German drug and chemical company whose products include the multiple sclerosis drug Rebif and cancer treatment Erbitux, said Monday that its fourth-quarter profit soared to nearly $5 billion as it reaped the benefits

German Merck Profit Soars on Serono Deal
FRANKFURT, Germany - Merck That move, the company said, meant 'Merck was able to repay essentially all the debt resulting from the purchase of Serono after less than one year.'Merck Chief Executive Karl-Ludwig Kley said the results -- both quarterly and

Germany's Merck 4Q profit soars near US$4.99B on Serono deal, generics sale
Canadian Press: Matt Moore, THE ASSOCIATED PRESS FRANKFURT, Germany - Merck KGaA, the German drug and chemical company whose products include the multiple sclerosis drug Rebif and cancer treatment Erbitux, says its fourth-quarter profit soared to nearly

German Merck Profit Soars on Serono Deal
Article: :/n/a/2008/02/18/financial/f072442S24.DTL SFGate HomeNews Business Sports Entertainment Travel | Classifieds Jobs Real Estate Cars SFGate Web Search by YAHOO! German Merck Profit Soars on Serono Deal del.icio.us Digg Technorati Reddit

German Merck Profit Soars on Serono Deal
Merck KGaA, the German drug and chemical company whose products include the multiple sclerosis drug Rebif and cancer treatment Erbitux, said Monday that its fourth-quarter profit soared to nearly $5 billion as it reaped the benefits of its acquisition of

AOptix Technologies Adds VP Of Operations To Launch Advanced Biometrics Iris Product
Pharma Industry / Biotech Industry News Main Category: Pharma Industry / Biotech Industry email to a friend printer friendly view / write opinions rate article newsletters AOptix Technologies, Inc., a leading edge developer of advanced iris

Germany's Merck 4Q profit soars near US$4.99B on Serono deal, generics sale
FRANKFURT, Germany - Merck KGaA, the German drug and chemical company whose products include the multiple sclerosis drug Rebif and cancer treatment Erbitux, says its fourth-quarter profit soared to nearly 3.4 billion euros (US$4.99 billion) from a year

German Merck Profit Soars on Serono Deal
German Drugmaker Merck's 4Q Profit Soars to Nearly $5B on Serono Deal, Generics Divestment NEW YORK (Associated Press) - Merck KGaA, the German drug and chemical company whose products include the multiple sclerosis drug Rebif and cancer treatment

German Drugmaker Merck's 4Q Profit Soars to Nearly $5B on Serono Deal, Generics Divestment
FRANKFURT, Germany (AP) - Merck KGaA, the German drug and chemical company whose products include the multiple sclerosis drug Rebif and cancer treatment Erbitux, said Monday that its fourth-quarter profit soared to nearly $5 billion as it reaped the

Cougar Biotechnology Presents Positive CB7630 Phase I And Phase II Data At ASCO 2008 Genitourinary Cancers Symposium
Prostate / Prostate Cancer News Main Category: Prostate / Prostate Cancer Also Included In: Urology / Nephrology; Cancer / Oncology email to a friend printer friendly view / write opinions rate article newsletters Cougar Biotechnology, Inc.

Indian Biotech Firm Buys into German Pharma Distributor
United Phosphorus Buys Columbian Agrochemicals FirmAir Liquide Posts Healthy Growth in Sales and EarningsGeorgia Gulfs Loss Widens; New CEO AppointedExchange Rates Boost Cambrexs EarningsGeneral Chemical to Form Soda Ash JV Related Stories Jubilant and

German drugmaker Merck's 4Q profit soars to nearly $5B on Serono deal, generics divestment
FRANKFURT, Germany - Merck KGaA, the German drug and chemical company whose products include the multiple sclerosis drug Rebif and cancer treatment Erbitux, said Monday that its fourth-quarter profit soared to nearly $5 billion as it reaped the benefits

Biosafety Bill for application of Biotechnology
Extract not available.

Biotechnology needs legislative environment
Extract not available.

Veritec to supply tribe with biometric IDs
UPI Senior News Analyst WASHINGTON, Feb. 15 (UPI) -- The commitment of the Bush administration and of planners in the U.S. Department of Defense to maintaining a powerful ground army for the United States is not in doubt. Published: Feb. 15, 2008 at 1:13

Gene chip technology used to distinguish ventilator-associated pneumonia from underlying critical illness
Critically ill patients who need a ventilator to breathe face a high risk of pneumonia. The lung infection, however, is exceedingly difficult to diagnose because a patient's underlying condition often skews laboratory test results and masks pneumonia's

Merck KGaA Q4 Profit Soars On Generics Sale Gain, Serono Acquisition; Sees Higher Revenue In FY08 [MKGAY.PK]
$1.25 - $1.29 Bln $1.28 - $1.32 Bln Gentiva Health Services 1.25 - 1.35 1.32 - 1.40 Canadian Stocks Look To Maintain Gains With US Markets Closed For Presidents Day - Canadian Commentary Asian Markets Remain Cautious- Asian Commentary Asian Bourses

Merck KGaA Q4 Profit Soars On Generics Sale Gain, Serono Acquisition; Sees Higher Revenue In FY08
More Breaking News about MKGAY.PK More Resources for MKGAY.PK (RTTNews) - German chemical and pharmaceutical company Merck KGaA (MKGAY.PK, MKGAF.PK) on Monday reported a surge in its fourth-quarter profit, mainly reflecting significantly higher one-time

Germany's Merck 4Q profit soars to nearly ?3.4B on Serono deal, divestment of generics unit
FRANKFURT, Germany_Merck KGaA, the German drug and chemical company whose products include the multiple sclerosis drug Rebif and cancer treatment Erbitux, said Monday that its fourth-quarter profit soared to nearly ?3.4 billion (US$4.99 billion) from a

Germany's Merck 4Q profit soars on Serono deal, divestment of generics unit
FRANKFURT, Germany-Merck KGaA, the German drug and chemical company, said Monday that its fourth-quarter profit soared to nearly 3.4 billion (US$4.99 billion) from a year ago as it reaped the benefits of its acquisition of Serono and the divestiture of

A Chip Off The Old Genome
-Until now, most physicians have made their medical decisions based solely upon generic professional knowledge and treatment experience, with little or no insight into the molecular nature of a patient s disease. Ever since the monumental achievement of

Amgen Tour of California top results
PALO ALTO, Calif., Top results Sunday from the 3.3-kilometre prologue of the Amgen Tour of California cycling race: 1. Fabian Cancellara, CSC, Switzerland, three minutes, 51.211 seconds, 51.449 km/hr; 2. Bradley Wiggins, High Road, Britain, 3:55.980; 3.